Genes with promoter regions containing the binding site for ELK1 were enriched in RA (binomial FDR 1.2 × 10−11) as well as in RA predicted by treatment (binomial FDR 2.7 × 10−15). Here, ELK1 is linked to rheumatoid arthritis.